A study looking at cancer cells and a substance called nucleic acid in the bloodstreams of women with breast cancer that has spread to other parts of the body (Detect)

Cancer type:

Breast cancer





This study is looking to find and study cancer cells and a substance containing gene (genetic) information called nucleic acid, in the bloodstream of women having treatment for breast cancer that has spread.

A cancer is made up of millions of cancer cells which form a tumour. Some cells may break away and spread to another part of the body, forming a new tumour. Breast cancer cells can spread from your original (primary) breast cancer to another part of your body in the bloodstream. This is called secondary breast cancer.

More about this trial

We know from research that studying cancer cells in the blood stream (circulating tumour cells or CTCs) could help doctors monitor how your cancer is responding to treatment. In future, CTCs may also help doctors understand more about how breast cancer spreads, so they can develop new treatments.

As well as studying CTCs, researchers are also interested in a substance called nucleic acid.  Nucleic acid carries genetic information, including information about gene faults in the cancer.  It is usually found in the control centre (nucleus) of the cell, but can also travel in the bloodstream ('circulating nucleic acid' or 'CNA').  So one day doctors could study genetic information about the cancer from a blood test rather than needing to take a sample of cancer tissue.  The aims of this study include

  • Testing new techniques to find the best way of finding and counting CTCs
  • Developing a record of characteristics (a ‘molecular profile’) of CTCs in women with breast cancer that has spread
  • Finding and studying the features of CNA
  • Looking to see if treatment causes changes in levels of CTC and CNA

You will not have any direct benefit from taking part in this study, and it will not change your treatment plan in any way. But the results of the study will be used to help people with cancer in the future.

Who can enter

You can enter this study if you are a woman under the care of Addenbrooke’s Hospital and you

You cannot enter this study if you have had another cancer (unless it was carcinoma in situ of the cervix, basal cell carcinoma or breast cancer that is only within the ducts of the breast (carcinoma in situ of the breast).

Trial design

This is a pilot study. It will recruit 500 patients as part of the pilot study.

Everyone will give up to 12 blood samples over 3 months, and permission for the research team to use information from their medical notes. The research team will treat your blood samples and medical information anonymously, so no one will be able to link your results to you.

If your cancer has spread to your lungs and you need treatment for fluid on the lung, the team may ask if they can study a sample of the fluid the doctor removes.

Hospital visits

Where possible, you will give your blood samples at the same time as your routine blood tests. So you should not have to make any extra hospital visits, or have any extra needles to take part in this study.

Side effects

You may have a small bruise where you had your blood test.



Recruitment start:

Recruitment end:

How to join a clinical trial

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Please note - unless we state otherwise in the summary, you need to talk to your doctor about joining a trial.

Chief Investigator

Professor Carlos Caldas

Supported by

Cambridge University Hospitals NHS Foundation Trust
Experimental Cancer Medicine Centre (ECMC)
University of Cambridge

Questions about cancer? Contact our information nurses

Freephone 0808 800 4040

Last review date

CRUK internal database number:


Please note - unless we state otherwise in the summary, you need to talk to your doctor about joining a trial.

Caroline took part in a clinical trial for breast cancer

“I had treatment last year and I want to give something back.”

Last reviewed:

Rate this page:

No votes yet
Thank you!
We've recently made some changes to the site, tell us what you think

Share this page